Viewing Study NCT00620633


Ignite Creation Date: 2025-12-25 @ 2:45 AM
Ignite Modification Date: 2026-02-22 @ 1:14 AM
Study NCT ID: NCT00620633
Status: COMPLETED
Last Update Posted: 2021-03-02
First Post: 2008-02-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Dose Escalation Trial of WT1-Sensitized T Cells for Residual or Relapsed Leukemia After Allogeneic Hematopoietic Progenitor Cell Transplantation
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module